Document is current
Any future updates will be listed below
-
Authors
Strug, Michael https://orcid.org/0000-0001-9784-889X
Aghajanova, Lusine
Khan, Maliha
Zhang, Jiaqi
Angress, Dan
Young, Steven L.
Lessey, Bruce
Lathi, Ruth B.
-
Funding
Funding for this research was provided by:
Small Business Innovative Research and Small Business Technology Transfer (R44HD097750)
- License Information
-
More Information
Article History
Received: 12 January 2025
Accepted: 11 June 2025
First Online: 27 June 2025
Declarations
:
: The study was approved by the Stanford University Institutional Review Board (IRB-51702) and was registered with ClinicalTrials.gov (NCT04107129).
: D.A. is Chief Operating Officer and Bruce Lessey is a Scientific Advisor for CiceroDx, Inc. who markets and sells the ReceptivaDx™ testing platform. All other authors have no relevant financial or non-financial interests to disclose.
